药品注册申请号:063329
申请类型:ANDA (仿制药申请)
申请人:PADAGIS US
申请人全名:PADAGIS US LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CLINDA-DERM CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE No No AT 1992/09/30 1992/09/30 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2019/09/05 SUPPL-6(补充) Approval Labeling STANDARD
1997/10/14 SUPPL-5(补充) Approval Manufacturing (CMC)
1997/10/14 SUPPL-4(补充) Approval Manufacturing (CMC)
1995/12/01 SUPPL-3(补充) Approval Manufacturing (CMC)
1993/07/14 SUPPL-2(补充) Approval Manufacturing (CMC)
1993/07/14 SUPPL-1(补充) Approval Manufacturing (CMC)
1992/09/30 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CLINDAMYCIN PHOSPHATE 剂型/给药途径:SOLUTION;TOPICAL 规格:EQ 1% BASE 治疗等效代码:AT
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
063329 001 ANDA CLINDA-DERM CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 1992/09/30 PADAGIS US
064050 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No Yes AT 1995/11/30 PADAGIS US
064159 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 1997/06/05 FOUGERA PHARMS INC
065184 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 2004/03/31 TARO PHARM INDS
206945 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Discontinued No No AT 2016/12/30 PAI HOLDINGS PHARM
209846 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 2018/02/08 CHARTWELL RX
208767 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 2018/07/16 ZYDUS LIFESCIENCES
209914 001 ANDA CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL EQ 1% BASE Prescription No No AT 2019/01/28 ENCUBE ETHICALS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database